Human herpesvirus 8 establishes a latent infection in prostates of Tobago men resulting in increased macrophage infiltration

Background The Caribbean island of Tobago, which is 97% African ancestry, has one of the highest rates of prostate cancer in the world. We have previously reported that human herpesvirus 8 (HHV‐8) infection is significantly associated with prostate cancer in Tobago. In this study, we extend those re...

Full description

Saved in:
Bibliographic Details
Published inThe Prostate Vol. 76; no. 8; pp. 735 - 743
Main Authors Henning, Jill D., Bunker, Clareann H., Patrick, Alan L., Jenkins, Frank J.
Format Journal Article
LanguageEnglish
Published United States Blackwell Publishing Ltd 01.06.2016
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background The Caribbean island of Tobago, which is 97% African ancestry, has one of the highest rates of prostate cancer in the world. We have previously reported that human herpesvirus 8 (HHV‐8) infection is significantly associated with prostate cancer in Tobago. In this study, we extend those results testing the hypothesis that HHV‐8 seropositive Tobagonian men have a chronic HHV‐8 infection in their prostates that is associated with increased inflammation. Methods Prostate sections were screened by immunohistochemistry for the expression of HHV‐8 proteins K8.1 and LANA‐1 and for presence of B cells (CD20) and macrophages (CD68). Results HHV‐8 antigen expression representing lytic and latent infections was seen in 73.9% of prostates from HHV‐8 seropositive subjects. Latent infections were seen predominantly in glandular epithelia whereas lytic gene expression was seen mainly in macrophages in prostate stroma. Macrophage infiltrates were significantly increased in sections expressing HHV‐8 proteins. Conclusion HHV‐8 establishes a chronic latent infection in the prostate, which is associated with an increased macrophage infiltrate. Prostate 76:735–743, 2016. © 2016 Wiley Periodicals, Inc.
Bibliography:National Institutes of Health - No. R01CA84950
Department of Defense - No. DAMD17-99-1-9015
istex:B8939DE14BAE2288C06B55BD2D7EA1302D21FC68
University of Pittsburgh Cancer Institute
ark:/67375/WNG-K168SC9N-2
ArticleID:PROS23163
Division of Health and Social Services
University of Pittsburgh Cancer Institute Cell and Tissue Imaging Facility - No. P30CA047904
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0270-4137
1097-0045
DOI:10.1002/pros.23163